-
Product Insights
Sinovac Biotech – Sinovac Vaccine Plant – Santiago Metropolitan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Sinovac Biotech - Sinovac Vaccine Plant - Santiago Metropolitan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Sinovac Biotech – Bogota Sinovac Vaccine Production Plant – Bogota D.C.
Equip yourself with the essential tools needed to make informed and profitable decisions with our Sinovac Biotech - Bogota Sinovac Vaccine Production Plant - Bogota D.C. report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Cambodia Pharma Ent/ Sinovac Life Sci – Tuol Ampil Covid-19 Vaccine Filing and Packaging Factory – Kandal
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cambodia Pharma Ent/ Sinovac Life Sci - Tuol Ampil Covid-19 Vaccine Filing and Packaging Factory - Kandal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our...
-
Company Profile
![]()
Sinovac Biotech Ltd – Company Profile
Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, an inactivated hepatitis A vaccine, bilive, a combined inactivated hepatitis A and B vaccine, anflu, a split viron influenza vaccine, panflu, a vaccine against the H5N1 influenza and inlive, an enterovirus type 71 vaccine. Sinovac Biotech also developed panflu.1, a vaccine against the influenza A H1N1 virus. The company conducts research to develop novel vaccines for infectious diseases includes SARS,...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rimtoregtide in Alcoholic Hepatitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Rimtoregtide in Alcoholic HepatitisDrug Details:Rimtoregtide is under development for the treatment of acute pancreatitis, alcoholic hepatitisand...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – pneumococcal (13-valent) vaccine in Streptococcal Pneumonia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pneumococcal (13-Valent) Vaccine in Streptococcal Pneumonia Drug Details:Pneumococcal vaccine (PCV13) is under development for Streptococcus pneumonia. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SAR-BBN in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SAR-BBN in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details: SAR-BBN is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Influenza [Strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (Quadrivalent, Split Virion) Vaccine in Seasonal Influenza
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Influenza [Strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (Quadrivalent, Split Virion) Vaccine in...
-
Sector Analysis
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Report Overview Pneumococcal Vaccines (PV) infections can broadly be classified into one of two types. In non-invasive pneumococcal disease, the infection does not penetrate normally sterile sites, such as the blood or cerebrospinal fluid (CSF). Infections tend to be mild in severity and can often resolve without treatment. Since there are several types of pneumococcal disease, symptoms depend on the part of the body that is infected, and range from fever, chills, and...
-
Track & Monitor
Clinical Trials – Impact of COVID-19 and Long COVID
This report provides an overview of global COVID-19 clinical trials, long COVID clinical trials, and trials disrupted by COVID-19.
-
Product Insights
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Poliomyelitis Pipeline Drugs Market Report Overview Polio is a highly infectious disease caused by a virus. It invades the nervous system and causes total paralysis in a matter of hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis pipeline drugs market research report provides comprehensive information on the Poliomyelitis targeted therapeutics, complete with analysis by indications, stage of development,...
-
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
COVID-19 Analyst Consensus Sales Report Overview Prophylactic COVID-19 vaccines are projected to generate total sales of $264 billion from 2021 to 2028. The number of COVID-19 drugs with forecast sales nearly tripled due to the massive mandatory vaccination campaigns led by the major markets, which caused rapid increases in COVID-19 vaccines. BioNTech/Pfizer’s Comirnaty, Moderna’s Spikevax, and Pfizer’s Paxlovid are the top three marketed drugs with the highest peak forecast sales. Comparing Q4 2020 and H2 2022 total COVID-19 forecast sales within...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Coronavirus Disease 2019 (COVID-19) vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Coronavirus Disease 2019 (COVID-19) vaccine Drug Details Coronavirus Disease 2019 (COVID-19) vaccine (CoronaVac) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine Drug...
-
Product Insights
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Rubella virus is transmitted by airborne droplets when infected people sneeze or cough. Its symptoms include fever, headache, stuffy or runny nose, inflamed, red eyes, aching joints and enlarged, tender lymph nodes at the base of the skull, the back of the neck, and behind the ears. The Rubella pipeline drugs market research report provides comprehensive information on the therapeutics under development for Rubella, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Product Insights
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Obesity is defined as having an excessive amount of body fat. Obesity increases the risk of diseases and health problems such as heart disease, diabetes, and high blood pressure. The predisposing factors include age, family history, smoking, lack of sleep, and certain medications. The obesity pipeline drugs market research report provides comprehensive information on the therapeutics under development for obesity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....
-
Product Insights
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Hepatitis B virus can cause an acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting, and abdominal pain. The Hepatitis B pipeline market research report provides comprehensive information on the therapeutics under development for Hepatitis B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hepatitis A symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of appetite, dark urine, muscle pain and yellowing of the skin and eyes (jaundice). Its treatment includes antiemetics and pain relievers. The Hepatitis A pipeline drugs market research report provides an analysis of the Hepatitis A drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer – August 2022
The urgent need for effective preventive vaccine and efficacious therapeutics for COVID-19 has given rise to an unprecedented pace of R&D by the biopharmaceutical industry, coupled with substantial investment by governments, non-profit agencies, and other stakeholders. There are currently more than 1,800Â assets in development for COVID-19, the majority of which are very early-stage or have little data available. The Coronavirus Disease 2019 (COVID-19) clinical and commercial analyzer report looks at the data from clinical trials for vaccines and therapeutics either...
-
Product Insights
Japanese Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Japanese Encephalitis – Drugs In Development, 2022, provides an overview of the Japanese Encephalitis (Infectious Disease) pipeline landscape. Japanese encephalitis is a viral disease that infects animals and humans. It is caused by a flavivirus that affects the membranes around the brain. It is transmitted by mosquitoes. Symptoms include fever, headache, muscle pain, diarrhea, seizures, muscle weakness and paralysis. Treatment targets relief of symptoms like pain relievers and anticonvulsants. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.